An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease.
Google’s Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care app
For the second time in as many years, Google’s health tech spinout Verily is pivoting. The company announced Tuesday that it will phase out its